About Dipanjan Banchur
Since he was in grade school, Dipanjan was interested in the stock market. This led to him obtaining a master’s degree in Finance and Accounting. Currently, as an investment analyst and financial journalist, Dipanjan has a strong interest in reading and analyzing emerging trends in financial markets. His goal is to help investors make the best investment decisions based on a fundamental approach.
Recent Articles By Dipanjan Banchur
2 Industrial Stocks to Buy, 1 to Avoid in 2024
The industrial sector’s growth prospects look promising due to improving supply chains, solid consumer demand trends, and the adoption and integration of advanced technologies. Therefore, one could consider investing in fundamentally strong industrial stocks Clear Water (CLW) and Steel Connect (STCN). On the other hand, avoiding Uranium Energy (UEC) could be prudent as it doesn’t look well positioned to capitalize on the industrial tailwinds. Read on…
Smart Tech Gains: 3 Stocks for Weekly Profits
The technology sector’s prospects appear promising due to increased digitization trends, sustained spending on public cloud services, and the adoption of new-age technologies. Hence, it could be wise to buy fundamentally strong tech stocks Cisco Systems (CSCO), Box (BOX), and Lantronix (LTRX) for gains. Read on...
3 Software Stocks for 2024 Portfolio Health and Beyond
The software industry’s growth prospects look promising thanks to continued digitalization initiatives, growing adoption of the public cloud, rise in cyber threats, and the integration of emerging technologies. Therefore, it could be wise to add fundamentally strong software stocks, Trend Micro (TMICY), RingCentral (RNG), and Karooooo (KARO), to one’s portfolio. Read on...
What’s the Best 2024 Pharma Stock Buy Among These 3 Stocks?
The pharma industry's potential for sustained growth is reinforced by an aging population, escalating healthcare demands, and the increase in chronic diseases. Therefore, let’s assess the fundamentals of pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Abbvie (ABBV) to determine the most promising choice for the current year…
Will These 3 Medical Stocks Make Gains in 2024?
Technological advances, rising healthcare costs, and the robust demand for medicines and healthcare services due to an aging population and the rise in chronic diseases are boosting the prospects of the medical sector. So, should you invest in Walgreens Boots Alliance (WBA), Tenet Healthcare (THC) and LifeVantage (LFVN) for gains? Read on...
Assessing Buy Opportunities in State Street (STT) and Regions Financial (RF) Prior to Earnings Releases
State Street (STT) and Regions Financial (RF) are scheduled to report their fourth-quarter results on January 19. Let’s assess whether it’s worth investing in these stocks ahead of their earnings reports…
3 Industrial Stocks Illuminating Gains in 2024
The industrial sector is poised for solid growth driven by the push for domestic manufacturing, easing of supply chains, strong demand for consumer goods in the end-user market, and the adoption of cutting-edge technologies. Therefore, investors could consider investing in fundamentally strong industrial stocks Siemens (SIEGY), IES Holdings (IESC), and Karat (KRT), given their promising growth prospects. Read on...
What to Expect in the Earnings Reports of M&T Bank (MTB) and Northern Trust (NTRS)
M&T Bank (MTB) and Northern Trust (NTRS) are expected to report their fourth-quarter earnings on January 18. Let’s discuss what investors need to know about their upcoming earnings…
Software Stock 2024 Watchlist
The software industry is poised for significant growth, fueled by digital transformation initiatives, a shift to cloud-based software solutions, and the adoption of advanced technologies like GenAI. Given this backdrop, it could be wise to add fundamentally strong software stocks ServiceNow (NOW), Informatica (INFA), Sprinklr (CXM), CSG Systems (CSGS), Weave (WEAV), and Kaltura (KLTR) to one’s watchlist. Read on…